Abstract: A strip of material for the delivery of an oral care active is disclosed. The strip of material includes a structural elastic-like film backing layer including a strainable network having a first region and a second region formed of substantially the same material composition, the first region providing a first, elastic-like resistive force to an applied axial elongation, and the second region providing a second distinctive resistive force to further applied axial elongation, thereby providing at least two stages of resistive forces in use; and an oral care composition disposed on the film, the oral care composition including an oral care active.

Abstract: A strip of material for the delivery of an oral care active is disclosed. The strip of material includes a structural elastic-like film backing layer including a strainable network having a first region and a second region formed of substantially the same material composition, the first region providing a first, elastic-like resistive force to an applied axial elongation, and the second region providing a second distinctive resistive force to further applied axial elongation, thereby providing at least two stages of resistive forces in use; and an oral care composition disposed on the film, the oral care composition including an oral care active.

Abstract: Described herein are systems and methods from delivering prosthetic devices, such as prosthetic heart valves, through the body and into the heart for implantation therein. The prosthetic devices delivered with the delivery systems disclosed herein are, for example, radially expandable from a radially compressed state mounted on the delivery system to a radially expanded state for implantation using an inflatable balloon of the delivery system. Exemplary delivery routes through the body and into the heart include transfemoral routes, transapical routes, and transaortic routes, among others.

Abstract: Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same.

Abstract: Provided herein is a compound, 1-(4-(3-amino-[1,2,3]triazolo[1,5-a]pyridin-4-yl)phenyl)-3-(3-chlorophenyl)urea, pharmaceutical compositions thereof, and crystal forms thereof. Also provided are particles (e.g., nanoparticles) comprising the compound, and pharmaceutical compositions thereof, that are mucus penetrating. Also provided herein are methods and kits for using the compound, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.

Abstract: Desensitizing oral care composition useful for treating dentinal hypersensitivity, comprising potassium oxalate and methods of use thereof. Delivery systems including a strip of material and such oral care compositions for the treatment of dentinal hypersensitivity and methods of use thereof.

Abstract: Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: An implantable prosthetic valve can include an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration. A leaflet structure can be positioned within the frame and secured thereto. An annular sealing member can be positioned around an outer surface of the frame, wherein the sealing member has a periodic, undulating shape. An outer skirt can be positioned around an outer surface of the sealing member and secured to the frame.

Abstract: Tether clamping assemblies, such as clamping assemblies used to clamp a tether about a spinal feature to assist in spinal fixation, and related methods and systems. In some embodiments, the assembly may comprise a tether configured to engage a bone or other anatomical feature, an inner coupling piece, and an outer coupling piece. A first passage may be at least partially defined by an inner surface of the outer coupling piece and an outer surface of the inner coupling piece. The first passage may be configured such that the tether can be clamped in between the inner surface and the outer surface to allow the tether to move through the first passage in a first direction and lock the tether in place. The inner and outer surfaces preferably differ in surface roughness to facilitate automatic or self-locking of the tether in the assembly.

Abstract: A stabilizing circuit is disclosed, which may be employed with lighting systems, such as with lighting system power supply operations. The circuit comprises a monitoring circuit configured to detect a characteristic of a power supply, and a switching controller configured to disconnect a primary load from the power supply and connect an auxiliary load to the power supply when the detected characteristic fails to meet a specified parameter. This is done to ensure compatibility and stability of both the power supply and the primary load. For example, when an AC mains voltage providing power to the power supply becomes unstable, the stabilizing circuit may be configured to prevent the power supply from remaining in a self-protection mode that may cause the primary load to become unstable. A method for stabilizing a circuit is also disclosed.

Abstract: Techniques for providing an uninterruptible power supply are disclosed. An example system includes three single-phase Uninterruptible Power Supplies (UPSs) and an adapter. The adapter is to receive three-phase AC power, and separate the three-phase AC power into three separate single-phase outputs. Each single-phase output is coupled to an input of one of the three single-phase UPSs. An output of each one of the single-phase UPSs is coupled to one of three single-phase inputs of the adapter, and the adapter is to combine the three single-phase inputs into a single three-phase output.

Abstract: Example implementations relate to placing loads in a self-refresh mode using a shared backup power supply. For example, a shared backup power supply system can include a node coupled to a shared backup power supply. The node can include a plurality of loads that include volatile memory and a processing resource to place the plurality of loads in a self-refresh mode in response to a failure of a primary power supply. A shared backup power supply system can also include the shared backup power supply to provide backup power to the plurality of loads in the self-refresh mode in response to the failure of the primary power supply.

Abstract: An uninterruptible power supply (UPS) includes a first battery set and a second battery set. The UPS includes a charging circuit to charge the battery sets using alternating current (AC) power. The UPS includes a slot receptive to insertion of different types of output modules that each include an inverter to convert direct current (DC) power from the first and second battery sets, including a first type that connects the first and second battery sets in parallel and a second type that connects the battery first and second sets in series.

Abstract: Described herein are systems and methods from delivering prosthetic devices, such as prosthetic heart valves, through the body and into the heart for implantation therein. The prosthetic devices delivered with the delivery systems disclosed herein are, for example, radially expandable from a radially compressed state mounted on the delivery system to a radially expanded state for implantation using an inflatable balloon of the delivery system. Exemplary delivery routes through the body and into the heart include transfemoral routes, transapical routes, and transaortic routes, among others.

Abstract: Examples disclosed herein involve backup power management. In an example, an amount of backup power to power a load bank is estimated, a set of power sources are selected from a plurality of power sources based on respective states of charge of the plurality of power sources and the estimated amount of backup power, and the selected set of power sources are placed in circuit to provide backup power to the load bank via the selected set of power sources.

Abstract: Provided herein is a compound, 1-(4-(3-amino-[1,2,3]triazolo[1,5-a]pyridin-4-yl)phenyl)-3-(3-chlorophenyl)urea, pharmaceutical compositions thereof, and crystal forms thereof. Also provided are particles (e.g., nanoparticles) comprising the compound, and pharmaceutical compositions thereof, that are mucus penetrating. Also provided herein are methods and kits for using the compound, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.

Abstract: Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: According to some examples, solutions are provided for power distribution of input alternating current (AC) power to at least one power outlet while the input AC power is available, charging of a set of batteries by the input AC power while the input AC power is available, and power distribution of direct current (DC) power from the set of batteries to the power outlet when the input AC power is not available. For such examples, the power outlet is capable of conducting AC power and DC power to a load that is coupled to the power outlet and that can receive either AC power or DC power.

Abstract: Example implementations relate to concurrent alternating-current and direct-current. In one example, a device comprises a power module connected to a first power outlet, the power module connected to a second power outlet, and a controller to the power module to concurrently provide alternating-current (AC) power to the first power outlet and direct-current (DC) power to the second power outlet by switching a transistor including switching circuitry in response to an absence of AC input power to the device.

Abstract: An example system is provided herein. The system includes a fuel cell coupled to the set of electronic components. The fuel cell provides power to the set of electronic components when a set of conditions are met.